DermaGen AB
🇸🇪Sweden
- Country
- 🇸🇪Sweden
- Ownership
- Private, Subsidiary
- Established
- 2004-05-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.dermagen.se
Clinical Trials
3
Active:1
Completed:2
Trial Phases
2 Phases
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 2
1 (50.0%)A Randomized, Double-blinded Placebo-controlled Study to Investigate Antimicrobial Efficacy and Safety Following Topical Application of DPK-060
Phase 1
Completed
- Conditions
- Atopic Dermatitis
- Interventions
- Drug: DPK-060 1% ointmentDrug: Placebo for DPK-060 ointment
- First Posted Date
- 2012-01-31
- Last Posted Date
- 2018-12-05
- Lead Sponsor
- DermaGen AB
- Target Recruit Count
- 41
- Registration Number
- NCT01522391
- Locations
- 🇸🇪
Quintiles Hermelinen AB, Luleå, Sweden
A Study of DPK-060 to Investigate Clinical Safety and Efficacy in Patients With Acute External Otitis
Phase 2
Completed
- Conditions
- Acute Otitis Externa
- Interventions
- Drug: Placebo for DPK-060 ear drops
- First Posted Date
- 2011-10-05
- Last Posted Date
- 2013-12-10
- Lead Sponsor
- DermaGen AB
- Target Recruit Count
- 69
- Registration Number
- NCT01447017
- Locations
- 🇸🇪
Hagakliniken, Gothenburg, Sweden
🇸🇪Me3+ Clinical Trials, Gothenburg, Sweden
🇸🇪Hallands Sjukhus, Halmstad, Sweden
News
No news found